Infectious Disease Treatment Market in China to Grow at A CAGR of 5.01% During The Period 2016-2020
©
About the Infectious Disease Treatment Market in China
Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, fungi, or viruses. They can be transmitted from one person to another through direct or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on target organism, anti-infective drugs can be categorized into antibacterial, antifungal, antiviral, and antiparasitic.
Read more at: http://www.researchbeam.com/infectious-disease-treatment-in-china-2016-2020-market
Researchbeam’s analysts forecast the Infectious Disease Treatment Market in China to Grow at A CAGR of 5.01% During The Period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
Researchbeam's report, Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F. Hoffmann-La Roche
• Gilead Sciences
• GSK
• Johnson & Johnson
• Merck
• Pfizer
Other prominent vendors
• Achaogen
• Actelion
• Adenovir Pharma
• AstraZeneca
• Bayer
• Biocryst
• Celsus therapeutics
• Cempra
• Eleven Biotherapeutics
• Exoxemis
• Ferrer International
• Griffin Discoveries
• Hexima
• InSite Vision
• Insmed Incorporated
• KaloBios Pharmaceuticals
• Lytix Biopharma
• Meiji Seika Pharma
• Melinta Therapeutics
• Moberg Pharma
• NanoViricides
• Nektar
• NicOx
• NovaBay
• NovaBiotics
• Ocular Therapeutix
• Panoptes Pharma
• Paratek Pharmaceuticals
• Polichem
• PTC Therapeutics
• RedHill
• Shire
• Starpharma Holdings
• Sun Pharma
• Symbiomix
• Tetraphase Pharmaceuticals
• The Medicines Company
• Theravance Biopharma
• Topica Pharmaceuticals
• Vertex Pharmaceuticals
• Viamet Pharmaceuticals
Market driver
• Use of combination therapies
• For a full, detailed list, view our report
Market challenge
• Development of drug resistant strains
• For a full, detailed list, view our report
Market trend
• Emergence of interferon (IFN)-free therapies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Request report sample @ http://www.researchbeam.com/infectious-disease-treatment-in-china-2016-2020-market/enquire-about-report
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
Market overview
Top-vendors
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: China - An overview
Social and economic conditions
Healthcare reforms
Healthcare infrastructure
PART 06: Opportunities for global and local vendors
Local vendors
Global vendors
PART 07: Pipeline analysis
AC-170
DEXTENZA
Zerbaxa
Surotomycin
MK-3415A
Amikacin Inhale
CARBAVANCE
Eravacycline. Etc.
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com
Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, fungi, or viruses. They can be transmitted from one person to another through direct or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on target organism, anti-infective drugs can be categorized into antibacterial, antifungal, antiviral, and antiparasitic.
Read more at: http://www.researchbeam.com/infectious-disease-treatment-in-china-2016-2020-market
Researchbeam’s analysts forecast the Infectious Disease Treatment Market in China to Grow at A CAGR of 5.01% During The Period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
Researchbeam's report, Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F. Hoffmann-La Roche
• Gilead Sciences
• GSK
• Johnson & Johnson
• Merck
• Pfizer
Other prominent vendors
• Achaogen
• Actelion
• Adenovir Pharma
• AstraZeneca
• Bayer
• Biocryst
• Celsus therapeutics
• Cempra
• Eleven Biotherapeutics
• Exoxemis
• Ferrer International
• Griffin Discoveries
• Hexima
• InSite Vision
• Insmed Incorporated
• KaloBios Pharmaceuticals
• Lytix Biopharma
• Meiji Seika Pharma
• Melinta Therapeutics
• Moberg Pharma
• NanoViricides
• Nektar
• NicOx
• NovaBay
• NovaBiotics
• Ocular Therapeutix
• Panoptes Pharma
• Paratek Pharmaceuticals
• Polichem
• PTC Therapeutics
• RedHill
• Shire
• Starpharma Holdings
• Sun Pharma
• Symbiomix
• Tetraphase Pharmaceuticals
• The Medicines Company
• Theravance Biopharma
• Topica Pharmaceuticals
• Vertex Pharmaceuticals
• Viamet Pharmaceuticals
Market driver
• Use of combination therapies
• For a full, detailed list, view our report
Market challenge
• Development of drug resistant strains
• For a full, detailed list, view our report
Market trend
• Emergence of interferon (IFN)-free therapies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Request report sample @ http://www.researchbeam.com/infectious-disease-treatment-in-china-2016-2020-market/enquire-about-report
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
Market overview
Top-vendors
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: China - An overview
Social and economic conditions
Healthcare reforms
Healthcare infrastructure
PART 06: Opportunities for global and local vendors
Local vendors
Global vendors
PART 07: Pipeline analysis
AC-170
DEXTENZA
Zerbaxa
Surotomycin
MK-3415A
Amikacin Inhale
CARBAVANCE
Eravacycline. Etc.
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com